Altorki N - Search Results

1

Infrequent point mutations of ras oncogenes in gastric cancers.

Nanus DM, Kelsen DP, Mentle IR, Altorki N, Albino AP. Nanus DM, et al. Among authors: altorki n. Gastroenterology. 1990 Apr;98(4):955-60. doi: 10.1016/0016-5085(90)90019-w. Gastroenterology. 1990. PMID: 2179035 Free article.

2

11p13-15 is a specific region of chromosomal rearrangement in gastric and esophageal adenocarcinomas.

Rodriguez E, Rao PH, Ladanyi M, Altorki N, Albino AP, Kelsen DP, Jhanwar SC, Chaganti RS. Rodriguez E, et al. Among authors: altorki n. Cancer Res. 1990 Oct 1;50(19):6410-6. Cancer Res. 1990. PMID: 2400998

3

The mutational status of p53 protein in gastric and esophageal adenocarcinoma cell lines predicts sensitivity to chemotherapeutic agents.

Nabeya Y, Loganzo F Jr, Maslak P, Lai L, de Oliveira AR, Schwartz GK, Blundell ML, Altorki NK, Kelsen DP, Albino AP. Nabeya Y, et al. Among authors: altorki nk. Int J Cancer. 1995 Feb 20;64(1):37-46. doi: 10.1002/ijc.2910640109. Int J Cancer. 1995. PMID: 7665247

4

Amplification of HER-2/neu gene in human gastric adenocarcinomas: correlation with primary site.

Albino AP, Jaehne J, Altorki N, Blundell M, Urmacher C, Lauwers G, Niedzwiecki D, Kelsen DP. Albino AP, et al. Among authors: altorki n. Eur J Surg Oncol. 1995 Feb;21(1):56-60. doi: 10.1016/s0748-7983(05)80069-1. Eur J Surg Oncol. 1995. PMID: 7851555

5

Defining the invasive phenotype of proximal gastric cancer cells.

Schwartz GK, Wang H, Lampen N, Altorki N, Kelsen D, Albino AP. Schwartz GK, et al. Among authors: altorki n. Cancer. 1994 Jan 1;73(1):22-7. doi: 10.1002/1097-0142(19940101)73:1<22::aid-cncr2820730106>3.0.co;2-o. Cancer. 1994. PMID: 8275429

6

Characterization of cell lines established from human gastric-esophageal adenocarcinomas. Biologic phenotype and invasion potential.

Altorki N, Schwartz GK, Blundell M, Davis BM, Kelsen DP, Albino AP. Altorki N, et al. Cancer. 1993 Aug 1;72(3):649-57. doi: 10.1002/1097-0142(19930801)72:3<649::aid-cncr2820720305>3.0.co;2-l. Cancer. 1993. PMID: 8334620

7

Validation of a Circulating Tumor DNA-Based Next-Generation Sequencing Assay in a Cohort of Patients with Solid tumors: A Proposed Solution for Decentralized Plasma Testing.

Al Zoughbi W, Fox J, Beg S, Papp E, Hissong E, Ohara K, Keefer L, Sigouros M, Kane T, Bockelman D, Nichol D, Patchell E, Bareja R, Karandikar A, Alnajar H, Cerqueira G, Guthrie VB, Verner E, Manohar J, Greco N, Wilkes D, Tagawa S, Malbari MS, Holcomb K, Eng KW, Shah M, Altorki NK, Sboner A, Nanus D, Faltas B, Sternberg CN, Simmons J, Houvras Y, Molina AM, Angiuoli S, Elemento O, Mosquera JM. Al Zoughbi W, et al. Among authors: altorki nk. Oncologist. 2021 Nov;26(11):e1971-e1981. doi: 10.1002/onco.13905. Epub 2021 Aug 4. Oncologist. 2021. PMID: 34286887 Free PMC article.

8

En bloc esophagectomy: the first 100 patients.

Altorki NK, Skinner DB. Altorki NK, et al. Hepatogastroenterology. 1990 Aug;37(4):360-3. Hepatogastroenterology. 1990. PMID: 2210601

9

Human lung cancer antigens recognized by autologous antibodies: definition of a novel cDNA derived from the tumor suppressor gene locus on chromosome 3p21.3.

Güre AO, Altorki NK, Stockert E, Scanlan MJ, Old LJ, Chen YT. Güre AO, et al. Among authors: altorki nk. Cancer Res. 1998 Mar 1;58(5):1034-41. Cancer Res. 1998. PMID: 9500467

10

mdm-2 expression correlates with wild-type p53 status in esophageal adenocarcinoma.

Soslow RA, Altorki NK, Yang G, Xie D, Yang CS. Soslow RA, et al. Among authors: altorki nk. Mod Pathol. 1999 Jun;12(6):580-6. Mod Pathol. 1999. PMID: 10392633

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

383 results

Search Page